These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 83057)

  • 1. [Monitoring the effectiveness of conservative treatment of benign prostatic hypertrophy by means of uroflowmetry].
    Tunn U; Senge T
    Z Urol Nephrol; 1978 Aug; 71(8):521-8. PubMed ID: 83057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of benign prostatic hypertrophy with gestonorone caproate].
    Baranowska B; Kuzaka B
    Pol Tyg Lek; 1984 Jul 16-23; 39(29-30):999-1003. PubMed ID: 6209689
    [No Abstract]   [Full Text] [Related]  

  • 3. [Conservative treatment of benign prostatic hyperplasia (author's transl)].
    Schoenenberger A; Hauri D
    Ther Umsch; 1982 Apr; 39(4):260-7. PubMed ID: 6179177
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacological combinations in the treatment of benign prostatic hypertrophy].
    Di Silverio F; D'Eramo G; Flammia GP; Buscarini M; Frascaro E; Mariani M; Sciarra A
    J Urol (Paris); 1993; 99(6):316-20. PubMed ID: 7516378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gestonorone therapy of prostatic adenoma].
    Lopatkin N; Darenkow A; Sahmatow J; Tankó A; Ignaschin N; Warentsow G
    Acta Chir Acad Sci Hung; 1980; 21(4):271-8. PubMed ID: 6175122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The treatment of benign enlargement of the prostate with nor progesterone caproate (primostat).
    Subbiah N; Mortensen J
    Aust N Z J Surg; 1973 Feb; 42(3):304-7. PubMed ID: 4129814
    [No Abstract]   [Full Text] [Related]  

  • 7. [Conservative treatment of benign prostatic hypertrophy: reevaluation of the effect of eviprostat by subjective symptoms and uroflowmetry].
    Matsuura T; Wakabayashi A; Kaneko S; Kurita T
    Hinyokika Kiyo; 1986 Jun; 32(6):903-6. PubMed ID: 2429533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of a double-blind study on the effectiveness of ERU (extractum radicis Urticae) capsules in conservative treatment of benign prostatic hyperplasia].
    Vontobel HP; Herzog R; Rutishauser G; Kres H
    Urologe A; 1985 Jan; 24(1):49-51. PubMed ID: 2580383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conservative treatment of benign prostatic hyperplasia.
    Palanca E; Juco W
    Curr Med Res Opin; 1977; 4(7):513-20. PubMed ID: 66118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentric, placebo-controlled, double-blind clinical trial of beta-sitosterol (phytosterol) for the treatment of benign prostatic hyperplasia. German BPH-Phyto Study group.
    Klippel KF; Hiltl DM; Schipp B
    Br J Urol; 1997 Sep; 80(3):427-32. PubMed ID: 9313662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of anti-androgen therapy for prostatic hypertrophy on lipid metabolism].
    Iguchi H; Ikeuchi T; Kai Y; Yoshida H
    Hinyokika Kiyo; 1994 Mar; 40(3):215-9. PubMed ID: 7513937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Medical therapy of benign prostatic hyperplasia: cyproterone acetate vs gestonorone caproate].
    Di Silverio F
    Minerva Urol Nefrol; 1986; 38(2):163-71. PubMed ID: 2428120
    [No Abstract]   [Full Text] [Related]  

  • 13. [An urodynamic study of patients with benign prostatic hypertrophy treated conservatively with phytotherapy or testosterone (author's transl)].
    Flamm J; Kiesswetter H; Englisch M
    Wien Klin Wochenschr; 1979 Sep; 91(18):622-7. PubMed ID: 90434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Changes in the echostructure of prostatic adenomas during drug therapy].
    Szutrely HP
    Med Klin Prax; 1982 Aug; 77(18):42-6. PubMed ID: 6182449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiandrogen therapy of benign prostatic hyperplasia--review of the agents evaluation of the clinical results].
    Kanimoto Y; Okada K
    Hinyokika Kiyo; 1991 Nov; 37(11):1423-8. PubMed ID: 1722627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depostat for benign prostatic hyperplasia?
    Drug Ther Bull; 1973 Sep; 11(19):75-6. PubMed ID: 4130364
    [No Abstract]   [Full Text] [Related]  

  • 17. Efficacy of high-energy transurethral microwave thermotherapy in alleviating medically refractory urinary retention due to benign prostatic hyperplasia.
    Kellner DS; Armenakas NA; Brodherson M; Heyman J; Fracchia JA
    Urology; 2004 Oct; 64(4):703-6. PubMed ID: 15491705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative treatment of benign prostatic hypertrophy with gestagen therapy by gestonorone caproate].
    Niijima T; Tanaka H; Takata M
    Hinyokika Kiyo; 1970 Sep; 16(9):508-22. PubMed ID: 4097363
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of Cernilton on benign prostatic hyperplasia].
    Ueda K; Jinno H; Tsujimura S
    Hinyokika Kiyo; 1985 Jan; 31(1):187-91. PubMed ID: 2581428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Results of treating prostatic adenoma with Depostat].
    Darenkov AF; Zakhvatov IuM; Tanko A; Ignashin NS; Varentsov GI
    Urol Nefrol (Mosk); 1980; (5):34-7. PubMed ID: 6158780
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.